Showing results (21-30 of 854) with videos related to
Sort By:
Pageof 86
Current Hematologic Malignancy Reports|June 7, 2012
Where does brentuximab vedotin fit into the management of patients with Hodgkin lymphoma?Sagun D Goyal, Nancy L BartlettCurrent Hematologic Malignancy Reports|March 21, 2016
Is There a Best Initial Treatment for a New Patient With Low Grade Follicular LymphomaCaron A Jacobson, Arnold S FreedmanCurrent Hematologic Malignancy Reports|May 20, 2016
Bending the Cost Curve in Childhood CancerHeidi Russell, M Brooke BernhardtCurrent Hematologic Malignancy Reports|September 26, 2017
Chronic Myeloid Leukemia-the Promise of Tyrosine Kinase Inhibitor DiscontinuationRavi Kishore Narra, Kathryn E Flynn, Ehab AtallahCurrent Hematologic Malignancy Reports|September 27, 2017
Molecular Pathogenesis of Myeloproliferative Neoplasms: Influence of Age and GenderJeffrey Patterson-Fortin, Alison R MoliternoCurrent Hematologic Malignancy Reports|September 27, 2017
Contemporary Use of Interferon Therapy in the Myeloproliferative NeoplasmsCharles Elliott Foucar, Brady Lee SteinCurrent Hematologic Malignancy Reports|August 2, 2017
Considerations in T Cell Therapy Product Development for B Cell Leukemia and Lymphoma ImmunotherapyAndrew D Fesnak, Patrick J Hanley, Bruce L LevineCurrent Hematologic Malignancy Reports|April 22, 2016
Novel Therapeutic Strategies in Acute Lymphoblastic LeukemiaAjoy Dias, Saad J Kenderian, Gustavo F Westin, et al.Current Hematologic Malignancy Reports|April 22, 2016
Managing Patients with Cutaneous B-Cell and T-Cell Lymphomas Other Than Mycosis FungoidesMeenal Kheterpal, Neha Mehta-Shah, Pooja Virmani, et al.Current Hematologic Malignancy Reports|March 18, 2016
Management of Patients with MYC-Altered LymphomasDaniel J LandsburgPageof 86